European Healthtech startup funding raised during Q2 2014.
In Q2 2014, 39 European Healthtech companies raised a combined €231M across 40 funding rounds, down 35.2% versus Q2 2013. Sweden led by capital raised, and Capricorn Venture Partners was the most active investor. Data as of 7 Aug 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Wilson Therapeutics | Other | Apr 2014 | €36M |
| Kymab | Series B | May 2014 | €29M |
| CRISPR Therapeutics | Series A | Apr 2014 | €23M |
| Voluntis | Series D+ |
| Apr 2014 |
| €21M |
| Sequana Medical | Series C | Apr 2014 | €17M |
| Bima | Series B | Apr 2014 | €16M |
| Lifeline Ventures Oy | Other | Apr 2014 | €15M |
| Enterome | Other | May 2014 | €10M |
| Nyxoah | Series A | May 2014 | €8.0M |
| OxThera | Other | Apr 2014 | €7.7M |
| Aleva Neurotherapeutics | Series B | May 2014 | €5.8M |
| Lifesum | Series A | Apr 2014 | €4.9M |
| Cartagenia | Other | May 2014 | €4.3M |
| Autifony Therapeutics | Other | Jun 2014 | €3.1M |
| Nuubo | Other | May 2014 | €3.0M |
